---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-23-001339"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2023-07-20T23:59:59+00:00"
generated_at: "2026-06-13T05:30:24.400531+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lexaria granted three US patents for DehydraTECH in hypertension and nicotine delivery

## Summary
- Issued US Patents #11,666,543 and #11,666,544 for DehydraTECH in treating hypertension.
- Issued US Patent #11,700,875 covering sublingual nicotine delivery via DehydraTECH.
- Plans to file FDA IND for DehydraTECH-CBD for hypertension soon.
- Ongoing study NIC-H22-1 tests DehydraTECH nicotine pouches vs commercial alternatives.

## SEC filing metadata
- accession: 0001640334-23-001339
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2023-07-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001339/0001640334-23-001339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001339/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-23-001339
- JSON: https://secwatch.observer/filing/0001640334-23-001339.json
- Plain text: https://secwatch.observer/filing/0001640334-23-001339.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.